OK-101 0.05%

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
The Study Assessing the Safety and Efficacy of OK-101 Treatment in Subjects With Neuropathic Corneal PainNCT06637527OKYOPhase 2Terminated2025-04-30Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.